MIR4465: A Drug Target / Disease Biomarker (G100616180)
MIR4465: A Drug Target / Disease Biomarker
MIR4465 is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells.
One of the unique features of MIR4465 is its ability to interact with various signaling molecules, including TGF-β1, a protein that plays a key role in cell growth and differentiation. This interaction between MIR4465 and TGF-β1 has led to the hypothesis that MIR4465 may be a drug target or biomarker for the treatment of various diseases, including cancer.
In addition to its interaction with TGF-β1, MIR4465 has also been shown to interact with several other signaling molecules, including the transcription factor, p53. This interaction between MIR4465 and p53 suggests that MIR4465 may also be involved in the regulation of cell growth and apoptosis.
MIR4465 has also been shown to play a role in the regulation of cellular transport processes. This interaction between MIR4465 and the protein known as EGFR, which is a transmembrane receptor that is involved in cell signaling, suggests that MIR4465 may be involved in the regulation of the delivery of substances from the cell surface to the inside of the cell.
In conclusion, MIR4465 is a protein that has been shown to interact with various signaling molecules, including TGF-β1, p53, and EGFR. These interactions suggest that MIR4465 may be involved in the regulation of cell growth, apoptosis, and cellular transport processes. As such, MIR4465 may be a drug target or biomarker for the treatment of various diseases, including cancer. Further research is needed to fully understand the role of MIR4465 in cell biology and to determine its potential as a therapeutic agent.
Protein Name: MicroRNA 4465
The "MIR4465 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4465 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655
